The PI3K/Akt/mTOR pathway is up-regulated in cancer due to several mechanism including activating mutations of PI3K and Akt, inactivating mutations of PTEN and over-expression of upstream receptors such as the tyrosine kinase human epithelial receptor family (HER). This evidence concerns the gene PTEN and cancer.